Position in LLY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$29,673,900
+$7,814,647 QoQ
Shares Held
24,740
+4.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#724
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BECKER CAPITAL MANAGEMENT INC holds $223,808,539 across 11 Drug Manufacturers - General names. LLY ranks #5 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
246,132 | $62,510,144 | |
| 2 | MRK |
Merck & Co., Inc.
|
268,226 | $34,467,041 | |
| 3 | AZN |
Astrazeneca PLC
|
176,512 | $33,470,205 | |
| 4 | AMGN |
Amgen Inc
|
85,085 | $30,810,980 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
24,740 | $29,673,900 | |
| 6 | SNY |
Sanofi
|
346,469 | $14,780,367 | |
| 7 | PFE |
Pfizer Inc
|
469,672 | $11,309,701 | |
| 8 | ABBV |
AbbVie Inc.
|
15,542 | $3,910,988 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,673,900 | 24,740 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $21,859,253 | 23,766 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $24,476,913 | 22,776 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $16,539,551 | 21,677 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $15,843,167 | 20,324 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,553,064 | 4,302 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $3,361,288 | 4,354 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,887,504 | 4,388 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $3,760,043 | 4,153 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $3,210,640 | 4,127 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,395,218 | 4,109 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,341,886 | 4,360 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,174,191 | 4,636 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,599,993 | 4,659 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,261,782 | 3,449 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,128,814 | 3,491 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,160,094 | 3,578 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $1,024,631 | 3,578 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $712,371 | 2,579 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $642,550 | 2,781 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $714,725 | 3,114 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $570,361 | 3,053 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $515,299 | 3,052 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $440,211 | 2,974 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $504,196 | 3,071 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $370,521 | 2,671 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||